ES2251403T3 - Fenil-alquenoilguanidinas sustituidas con acido biliar, procedimiento para su preparacion, su uso como medicamentos o agentes de diagnostico, asi como medicamentos que las contienen. - Google Patents

Fenil-alquenoilguanidinas sustituidas con acido biliar, procedimiento para su preparacion, su uso como medicamentos o agentes de diagnostico, asi como medicamentos que las contienen.

Info

Publication number
ES2251403T3
ES2251403T3 ES00958461T ES00958461T ES2251403T3 ES 2251403 T3 ES2251403 T3 ES 2251403T3 ES 00958461 T ES00958461 T ES 00958461T ES 00958461 T ES00958461 T ES 00958461T ES 2251403 T3 ES2251403 T3 ES 2251403T3
Authority
ES
Spain
Prior art keywords
alkyl
phenyl
hydrogen
substituted
methoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00958461T
Other languages
English (en)
Spanish (es)
Inventor
Heinz-Werner Kleemann
Armin Hofmeister
Eugen Falk
Hans-Willi Jansen
Hans-Ludwig Schaefer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Sanofi Aventis Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland GmbH filed Critical Sanofi Aventis Deutschland GmbH
Application granted granted Critical
Publication of ES2251403T3 publication Critical patent/ES2251403T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C07J41/0061—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives one of the carbon atoms being part of an amide group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES00958461T 1999-09-02 2000-08-17 Fenil-alquenoilguanidinas sustituidas con acido biliar, procedimiento para su preparacion, su uso como medicamentos o agentes de diagnostico, asi como medicamentos que las contienen. Expired - Lifetime ES2251403T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19941764 1999-09-02
DE19941764A DE19941764A1 (de) 1999-09-02 1999-09-02 Substituierte Acylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikamente oder Diagnostika sowie sie enthaltende Medikamente

Publications (1)

Publication Number Publication Date
ES2251403T3 true ES2251403T3 (es) 2006-05-01

Family

ID=7920512

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00958461T Expired - Lifetime ES2251403T3 (es) 1999-09-02 2000-08-17 Fenil-alquenoilguanidinas sustituidas con acido biliar, procedimiento para su preparacion, su uso como medicamentos o agentes de diagnostico, asi como medicamentos que las contienen.

Country Status (11)

Country Link
US (1) US6451781B1 (cg-RX-API-DMAC7.html)
EP (1) EP1248768B1 (cg-RX-API-DMAC7.html)
JP (1) JP4768941B2 (cg-RX-API-DMAC7.html)
AT (1) ATE309981T1 (cg-RX-API-DMAC7.html)
AU (1) AU774083B2 (cg-RX-API-DMAC7.html)
CA (1) CA2383729A1 (cg-RX-API-DMAC7.html)
DE (2) DE19941764A1 (cg-RX-API-DMAC7.html)
DK (1) DK1248768T3 (cg-RX-API-DMAC7.html)
ES (1) ES2251403T3 (cg-RX-API-DMAC7.html)
IL (1) IL148250A0 (cg-RX-API-DMAC7.html)
WO (1) WO2001017954A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ563604A (en) * 2001-11-29 2009-04-30 Theracos Inc Compounds for treatment of inflammation, diabetes and related disorders
WO2018129556A1 (en) * 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US10543207B2 (en) 2008-12-31 2020-01-28 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
CN103819403B (zh) * 2008-12-31 2017-01-04 阿德利克斯公司 用于治疗与体液潴留或盐超负荷有关的病症和胃肠道病症的化合物和方法
MX363056B (es) * 2012-08-21 2019-03-06 Ardelyx Inc Compuestos y metodos para inhibir al antipuerto mediado por nhe en el tratamiento de trastornos asociados con la retencion de fluidos o la sobrecarga de sal y trastornos del tracto gastrointestinal.
CN105392483B (zh) 2013-04-12 2019-03-15 阿德利克斯公司 用于抑制磷酸盐转运的nhe3结合化合物和方法
EA201991676A1 (ru) 2017-01-09 2020-01-30 Арделикс, Инк. Ингибиторы nhe-опосредованного антипорта
KR20240090875A (ko) 2017-01-09 2024-06-21 알데릭스, 인코포레이티드 위장관 장애를 치료하는 데 유용한 화합물
US12186329B2 (en) 2018-08-23 2025-01-07 President And Fellows Of Harvard College Compositions and methods related to cholic acid 7-sulfate as a treatment for diabetes
WO2020117945A1 (en) 2018-12-04 2020-06-11 President And Fellows Of Harvard College Synthetic derivatives of cholic acid 7-sulfate and uses thereof
CN120757601A (zh) 2019-05-10 2025-10-10 哈佛大学的校长及成员们 肠道细菌胆汁酸代谢的小分子调节剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0667846B2 (ja) * 1989-04-28 1994-08-31 一 滝川 利胆剤
TW289021B (cg-RX-API-DMAC7.html) 1993-05-08 1996-10-21 Hoechst Ag
IT1274000B (it) * 1994-04-06 1997-07-14 Alfa Wassermann Spa Derivati di acidi biliari utili nella terapia della calcolosi biliare da colesterolo e nelle patologie indotte da colestasi
JPH09315979A (ja) * 1996-05-24 1997-12-09 Tokyo Tanabe Co Ltd 利胆剤
DE19849722A1 (de) * 1998-10-28 2000-05-04 Aventis Pharma Gmbh Substituierte Phenyl-alkenoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
CA2383729A1 (en) 2001-03-15
JP4768941B2 (ja) 2011-09-07
DE50011660D1 (de) 2005-12-22
ATE309981T1 (de) 2005-12-15
DE19941764A1 (de) 2001-03-15
IL148250A0 (en) 2002-09-12
AU6996500A (en) 2001-04-10
US6451781B1 (en) 2002-09-17
AU774083B2 (en) 2004-06-17
EP1248768A1 (de) 2002-10-16
WO2001017954A1 (de) 2001-03-15
EP1248768B1 (de) 2005-11-16
JP2003508513A (ja) 2003-03-04
DK1248768T3 (da) 2006-03-27

Similar Documents

Publication Publication Date Title
TW534910B (en) Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4
JP4616479B2 (ja) 胆汁酸で置換されたフェニルアルケノイルグアニジン類、その製造方法、その薬剤または診断薬としての使用、およびそれらを含有する薬剤
US5086069A (en) Anti-thrombotic peptide and pseudopeptide derivatives
EP1608671B1 (en) Oestrogen derivatives as inhibitors of steroid sulphatase
JPH0532634A (ja) ピペリジニルカンホスルホニルオキシトシン拮抗剤
TW200400946A (en) Heterocyclic compounds which inhibit leukocyte adhesion mediated by α 4 integrins
TW200410983A (en) Novel glucocorticoid receptor ligands for the treatment of metabolic disorders
AU774083B2 (en) Bile acid-substituted phenyl-alkenoylguanidines, method for producing said phenyl-alkenoylguanidines, use thereof as medicaments or diagnostic reagents and medicaments containing the same
ES2218222T3 (es) Conjugados de 4-bencilaminoquinolinas con acidos biliares y sus heteroanalogos, procedimiento para su preparacion, medicamentos que contienen estos compuestos y su uso.
ES2201440T3 (es) S-2'-(2-(1-metil-2-piperidil)etil)cinnamanilida como antagonista del receptor 5-ht2.
ES2512991T3 (es) Derivados diterpenoides provistos de propiedades biológicas
MXPA02002181A (es) Fenil-alquenoilguanidinas substituidas del acido biliar, proceso para su preparacion, su uso como medicamentos o agentes de diagnostico, y medicamentos que contienen las mismas.
JPH0859635A (ja) エンドセリン受容体拮抗作用を有するスルホンアミド誘導体
LT3681B (en) N-acyl-alpha-amino acid derivatives, method for producting thereof,pharmaceutical compositions and preparing them
DE19945385A1 (de) Substituierte 4-Benzylaminochinoline und ihre Heteroanlagen, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
CZ20011151A3 (cs) Deriváty propanolaminu vázané s kyselinou žlučovou pro léčení poruch metabolismu lipidů